QSAR analysis of interstudy variable skin permeability based on the "latent membrane permeability" concept

Journal of Pharmaceutical Sciences

Volumn 92, Issue 10, 2003, Pages 1939-1946

  Fujiwara, Shin Ichi ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Latent membrane permeability concept; Multivariate analysis; Passive diffusion transport; Permeability; QSAR; QSPR; Skin

Indexed keywords

ALCOHOL; HYDROCORTISONE; NARCOTIC ANALGESIC AGENT; OCTANOL; PHENOL DERIVATIVE; STEROID; WATER;

ANIMAL TISSUE; ARTICLE; HUMAN; HUMAN TISSUE; MATHEMATICAL ANALYSIS; MEMBRANE PERMEABILITY; MOLECULAR WEIGHT; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PARTITION COEFFICIENT; PASSIVE TRANSPORT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RAT; REGRESSION ANALYSIS; SKIN PERMEABILITY; STATISTICAL ANALYSIS;

EID: 0141731271     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10462     Document Type: Article

References (31)

1. Flynn GL. 1990. Physiochemical determinants of skin absorption. In: Gerrity TR, Henry CJ, editors. Principles of route-to-route extrapolation for risk assessment. New York: Elsevier, pp 93-127.
2. Tayar NE, Tsai RY, Testa B, Carrupt PA, Hansch C, Leo A. 1991. Percutaneous penetration of drugs: A quantitative structure-permeability relationship study. J Pharm Sci 80:744-749.
3. Kasting GB, Smith RL, Cooper ER. 1987. Effect of lipid solubility and molecular size on percutaneous absorption. In: Shroot B, Schaefer H, editors. Skin pharmacokinetics. Basel: Karger, pp 138-153.
4. Potts RO, Guy RH. 1992. Predicting skin permeability. Pharm Res 9:663-669.
5. Pugh WJ, Hadgraft J. 1994. Ab initio prediction of human skin permeability coefficients. Int J Pharm 103:163-178.
6. Wilschut A, Berge WF, Robinson PJ, McKone TE. 1995. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 30:1275-1296.
7. Lien EJ, Gao H. 1995. QSAR analysis of skin permeability of various drugs in man as compared to in vivo and in vitro studies in rodents. Pharm Res 12:583-587.
8. Abraham MH, Chadha SH, Mitchell RC. 1995. The factors that influence skin penetration of solutes. J Pharm Pharmacol 47:8-16.
9. Robert MS, Pugh WJ, Hadgraft J, Watkinson AC. 1995. Epidermal permeability-penetrant structure relationships: 2, An analysis of methods of predicting penetration of monofunctional solutes from aqueous solutions. Int J Pharm 126:219-233.
10. Potts RO, Guy RH. 1995. A predictive algorithm for skin permeability: The effects of molecular size and hydrogen bond activity. Pharm Res 12:1628-1633.
11. Abraham MH, Martins F, Mitchell RC. 1997. Algorithms for skin permeability using hydrogen bond descriptors: The problem of steroids. J Pharm Pharmacol 49:858-865.
12. Pugh WJ, Degim IT, Hadgraft J. 2000. Epidermal permeability-penetrant structure relationships: 4, QSAR ofpermeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electric charge. Int J Pharm 197:203-211.
13. Buchwald P, Bodor N. 2001. A simple, predictive, structure-based skin permeability. J Pharm Pharmacol 53:1087-1098.
14. Ohkura K, Hori H. 1999. Analysis of structure-permeability correlation of nitrophenol analogues in newborn rat abdominal skin using semiempirical molecular orbital calculation. Bioorg Med Chem 7:309-314.
15. Lim CW, Fujiwara S, Yamashita F, Hashida M. 2002. Prediction of human skin permeability using a combination of MO-calculations and artificial neural network. Biol Pharm Bull 25:361-366.
16. Johnson ME, Blankschtein D, Langer R. 1995. Permeation ofsteroids through human skin. J Pharm Sci 84:1144-1146.
17. Scheuplein RJ, Blank IH, Brauner GJ, MacFarlane DJ. 1969. Percutaneous absorption of steroids. J Invest Dermatol 52:63-70.
18. Anderson BD, Higuchi WI, Raykar PV. 1988. Heterogeneity effects on permeability-partition coefficient relationships in human stratum corneum. Pharm Res 5:566-573.
19. Yamashita F, Fujiwara S, Hashida M. 2002. The "latent membrane permeability" concept: QSPR analysis of inter/intralaboratorically variable Caco-2 permeability. J Chem Inf Comput Sci 42:408-413.
20. Scheuplein RJ. 1965. Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility. J Invest Dermatol 45:334-345.
21. Michaels AS, Chandrasekaran SK, Shaw JE. 1975. Drug permeation through human skin-Theory and in vitro experimental measurement. Am Inst Chem Eng 21:985-996.
22. Roberts MS, Anderson RA, Swarbrick J. 1977. Permeability of human epidermis to phenolic compounds. J Pharm Pharmacol 29:677-683.
23. Hadgraft J, Ridout G. 1987. Development of model membranes for percutaneous absorption measurements. I. Isopropyl myristate. Int J Pharm 39:149-156.
24. Roy SD, Flynn GL. 1989. Transdermal delivery of narcotic analgesics: comparative permeabilities of narcotic analgesics through human cadaver skin. Pharm Res 6:825-832.
25. Mitragotli S, Edwards DA, Blankschtein D, Langer R. 1995. A mechanistic study of ultrasonically-enhanced transdermal drug delivery. J Pharm Sci 84:697-706.
26. Durrheim H, Flynn GL, Higuchi WI, Berl C. 1980. Permeation of hairless mouse skin. I: Experimental methods and comparison with human epidermal permeation by alkanols. J Pharm Sci 69: 781-786.
27. Hatanaka T, Inuma M, Sugibayashi K, Morimoto Y. 1992. Prediction of skin permeability of drugs. II. Development of composite membrane as a skin alternative. Int J Pharm 79:21-28.
28. Bartek MJ, LaBudde JA, Maibach HI. 1972. Skin permeability in vivo: Comparison in rat, rabbit, pig and man. J Invest Dermatol 58:114-123.
29. Bronaugh RL, Stewart RF, Congdon ER. 1982. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol Appl Pharmacol 62:481-488.
30. Morimoto Y, Hatanaka T, Sugibayashi K, Omiya H. 1992. Prediction ofskin permeability of drugs: Comparison of human and hairless rat skin. J Pharm Pharmacol 44:634-639.
31. Efron B. 1979. Bootstrap methods: Another look at the jack-knife. Ann Stat 7:1-26.